Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Shih‐Syuan Wang"'
Autor:
Cho‐Han Chiang, Yu‐Cheng Chang, Shih‐Syuan Wang, Yuan‐Jen Chen, Xin Ya See, Chun‐Yu Peng, Yuan Ping Hsia, Cho‐Hsien Chiang, Cho‐Hung Chiang, Cheng‐Ming Peng
Publikováno v:
Cancer Medicine, Vol 12, Iss 8, Pp 9583-9588 (2023)
Abstract Background Certain angiotensin receptor blockers (ARBs) have peroxisome proliferator‐activated receptor‐γ (PPAR‐γ) activation property, which has been associated with improved programmed cell death ligand 1 blockade and cytotoxic T l
Externí odkaz:
https://doaj.org/article/899860dbd8674a6fb8079d77723d06b4
Autor:
Wan-Ying Lin, Shih-Syuan Wang, Yi-No Kang, Andrea S. Porpiglia, Yu Chang, Chin-Hsuan Huang, Ronak Bhimani, Eahab Abdul-Lattif, Muneeba Azmat, Tsu-Hsien Wang, Yu-Shiuan Lin, Yu-Cheng Chang, Kuan-Yu Chi
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Proton pump inhibitors (PPI), one of the most commonly prescribed medications, carry a myriad of adverse events. For colorectal cancer (CRC) patients, it still remains unclear whether the concurrent use of proton pump inhibitors (PPI) would negativel
Externí odkaz:
https://doaj.org/article/7c34aad77b7e4eb78b531ae1b0688b8e
Autor:
Cho-Han Chiang, Yuan-Jen Chen, Cho-Hsien Chiang, Cheng-Ying Chen, Yu-Cheng Chang, Shih-Syuan Wang, Xin Ya See, Chuan-Sheng Horng, Chun-Yu Peng, Yuan Ping Hsia, Cheng-Ming Peng, Cho-Hung Chiang
Publikováno v:
Cancer Immunology, Immunotherapy. 72:1951-1956
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c35cb6ba7f58cd97395b7351c4f66c51
https://doi.org/10.1007/s00262-022-03363-6
https://doi.org/10.1007/s00262-022-03363-6
Autor:
Cho-Han Chiang, Cho-Hung Chiang, Cho-Hsien Chiang, Kevin Sheng-Kai Ma, Chun-Yu Peng, Yuan Ping Hsia, Chuan-Sheng Horng, Cheng-Ying Chen, Yu-Cheng Chang, Xin Ya See, Yuan-Jen Chen, Shih-Syuan Wang, Giselle A Suero-Abreu, LR Peterson, Paaladinesh Thavendiranathan, Philippe Armand, Cheng-Ming Peng, Her-Shyong Shiah, Tomas G Neilan
Publikováno v:
Heart
ObjectivesSodium-glucose cotransporter-2 inhibitors (SGLT2i) reduce heart failure (HF) in at-risk patients and may possess antitumour effects. We examined the effect of SGLT2i on HF and mortality among patients with cancer and diabetes.MethodsThis wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fad28687ea28a167810df6ddcf36a018
https://europepmc.org/articles/PMC10037540/
https://europepmc.org/articles/PMC10037540/
Autor:
Cho-Han Chiang, Cho-Hung Chiang, Chun-Yu Peng, Yuan Ping Hsia, Xin Ya See, Chuan-Sheng Horng, Yu-Cheng Chang, Xuan-Er Shen, Shih-Syuan Wang, Tien-Chi Tsai, Yuan-Jen Chen, Kevin Sheng-Kai Ma, Brian Shiian Chen, Yu-Ze Luan, Soon-Tzeh Tay, Chin-Hsuan Shen, Katharine Ching Chung, Cho-Hsien Chiang, Cheng-Ming Peng
Publikováno v:
European journal of cancer (Oxford, England : 1990). 174
Cationic amphiphilic antihistamines have been shown to improve patient outcomes in immunogenic tumours, but whether they can augment and improve response to immunotherapy is unknown. We aim to evaluate the effect of cationic amphiphilic antihistamine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9e865b78eb64809ea479dd4afe49777
https://pubmed.ncbi.nlm.nih.gov/35964360
https://pubmed.ncbi.nlm.nih.gov/35964360